Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 May;53(5):2139-41.
doi: 10.1128/AAC.00090-09. Epub 2009 Mar 2.

Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101

Ken B Waites  1 , D M Crabb, Lynn B Duffy
Affiliations
Comparative Study

Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101

Ken B Waites et al. Antimicrob Agents Chemother. 2009 May.

Abstract

MICs were determined for an investigational ketolide, CEM-101, and azithromycin, telithromycin, doxycycline, levofloxacin, clindamycin, and linezolid against 36 Mycoplasma pneumoniae, 5 Mycoplasma genitalium, 13 Mycoplasma hominis, 15 Mycoplasma fermentans, and 20 Ureaplasma isolates. All isolates, including two macrolide-resistant M. pneumoniae isolates, were inhibited by CEM-101 at < or = 0.5 microg/ml, making CEM-101 the most potent compound tested.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bebear, C. M., H. Renaudin, A. Charron, D. Gruson, M. Lefrancois, and C. Bebear. 2000. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob. Agents Chemother. 44:2557-2560. - PMC - PubMed
    1. Biedenbach, D. J., L. M. Deshpande, T. R. Fritsche, H. S. Sader, and R. N. Jones. 2008. Antimicrobial characterization of CEM-101: activity against enterococci, uncommon gram-positive pathogens, N. gonorrhoeae and anaerobes, abstr. F1-3976. 48th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC.
    1. Duffy, L., J. Glass, G. Hall, R. Avery, R. Rackley, S. Peterson, and K. Waites. 2006. Fluoroquinolone resistance in Ureaplasma parvum in the United States. J. Clin. Microbiol. 44:1590-1591. - PMC - PubMed
    1. Jensen, J. S., C. S. Bradshaw, S. N. Tabrizi, C. K. Fairley, and R. Hamasuna. 2008. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin. Infect. Dis. 47:1546-1553. - PubMed
    1. Jones, R. N., D. J. Biedenbach, P. R. Rhomberg, T. R. Fritsche, and H. S. Sader. 2008. Antimicrobial characterization of CEM-101 activity against 331 respiratory tract pathogens including multidrug-resistant pneumococcal serogroup 19A (MDR-19A) isolates, abstr. F1-3975. 48th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC. - PubMed

Publication types

MeSH terms